D, G., A, M., A, C., G, G., F, S., N, K. H., . . . L, D. M. (2025). Beyond the BRCA1/2 genes in ovarian cancer: The role of germline pathogenic variants in the ATM gene. Molecular biology reports, 52(1), 261. https://doi.org/10.1007/s11033-025-10357-x
Chicago Style (17th ed.) CitationD, Guadagnolo, et al. "Beyond the BRCA1/2 Genes in Ovarian Cancer: The Role of Germline Pathogenic Variants in the ATM Gene." Molecular Biology Reports 52, no. 1 (2025): 261. https://doi.org/10.1007/s11033-025-10357-x.
MLA (9th ed.) CitationD, Guadagnolo, et al. "Beyond the BRCA1/2 Genes in Ovarian Cancer: The Role of Germline Pathogenic Variants in the ATM Gene." Molecular Biology Reports, vol. 52, no. 1, 2025, p. 261, https://doi.org/10.1007/s11033-025-10357-x.